Magnetic nanoparticles: a breakthrough in medicine - how "smart" particles learned to bypass the labyrinths of blood vessels and are already preparing for the clinic

Lightning-fast drug delivery through the complex “highways” of the circulatory system, personalized oncology therapy, and treatment of strokes without scalpels are no longer fantasy, but medical realities of the end of 2025. Magnetic nanoparticles, which, under the control of an external magnetic field, are capable of “crawling” through even the most complex vessels, are completing a cycle of animal tests and are preparing for the first clinical tests on humans. How does this “navigation” work, what is the revolution for oncology, cardiology, and neurology, is this technology safe, and what place do Ukrainian scientists occupy in this breakthrough?

Directing technique: how magnetic nanoparticles overcome the “microlabyrinths” of blood vessels

Modern magnetic nanoparticles are up to 100 nm in size, contain ferrite or iron oxide, are inert and biocompatible¹Thanks to an external controlled magnetic field, a doctor or an artificial intelligence system can direct them to the most distant capillaries, “bypassing” branches, turbulence zones and variable blood flow velocity.²This allows for targeted delivery of drugs (anticancer drugs, antibiotics, enzymes for dissolving blood clots) — even into the brain or deep liver lesions, which was previously impossible due to natural barriers.

In animal experiments, nanoparticles equipped with sensors and nanopumps were able to effectively traverse complex vessel models under live observation of magnetic scanners, selectively accumulating at the site of pathology.³

Working principle: what distinguishes new generation magnetic nanoparticles from classic drugs?

• Punctuality of delivery: magnets allow you to “direct” particles to a specific organ or tumor without harming the entire body, like traditional chemotherapy.
• Minimizing side effects: the medicine does not spread throughout the body and does not cause “intoxication”, as with classical administration.
• Real-time management: magnetic scanners and computer navigation allow you to see the path of “medical nanorobots” and adjust it even during the procedure.
• Possibility of multiple delivery: particles can be modified for reactivation and subsequent use.⁴

Clinical Perspectives: How Close Is Medicine to “Nanobots” in the Blood?

Studies in 2024–2025 on mice, rabbits, and pigs proved the ability of such nanoparticles to overcome not only straight vessels, but also complex nodes, areas with intense blood flow, and pass through brain barriers.¹ In several experiments, magnetic navigation has successfully delivered anticoagulants to blood clots in the brain's vessels and eliminated the effects of experimental stroke by injection.⁵

The first stages of clinical trials in Switzerland, the USA, and Singapore have already shown the safety of the technology for humans: side effects are rare and mostly limited to local vascular irritation.⁶

Areas of application: from head and neck cancer to aneurysm treatment

• Oncology: delivery of cytostatics and immunotherapeutic drugs to the tumor without damaging healthy tissues.
• Cardiology: dissolving blood clots in the vessels of the heart and brain during heart attacks and strokes.
• Neurology: neuroprotective and anti-inflammatory agents in multiple sclerosis, diabetic retinopathy.
• Microsurgery: point-to-point delivery of “smart” sensors for diagnosing or “sealing” damaged vessels (for example, in brain aneurysms).⁷

For example, in 2025, a team from ETH Zurich first demonstrated the navigation of iron oxide nanoparticles in ultrathin vessels of the brain — where even the most advanced catheters cannot reach.⁸

Security and restrictions: real risks and challenges

Although studies show minimal health risks, scientists emphasize: long-term exposure and repeated procedures require monitoring¹Key issues include the risk of microvascular blockage (if particles are larger than 200 nm), adverse reactions to nanomaterials, and precision of control in complex anatomies.
Absorbable nanoparticles are currently being developed that do not linger in tissues and do not cause inflammation after drug delivery.⁹

Experience and contribution of Ukrainian scientists

Ukraine is among the leaders in research into the chemistry of nanomaterials for medical purposes: a number of works by the Academy of Sciences and specialized departments have proven the safety of new carriers for antibiotics, immunomodulators, and antitumor agents²Domestic physicists and pharmacists are researching compounds for point action inside the body and impact on tumors even at minimal doses of the active substance.

Ukrainian scientists are integrated into European grants, experimental programs Horizon2025 and CORDIS, work is underway at the intersection of chemistry, physics, and biotechnology.

What's next? When "nanobots" reach the clinic

Experts predict that in the next 1–3 years, magnetic navigation of nanoparticles will become commonplace in large clinics to increase the effectiveness of chemotherapy for liver, head, and brain cancer, and for an almost bloodless fight against strokes and thrombosis.⁶
Next is the emergence of “autonomous” nanobots with navigation based on neural networks, which can independently recognize lesions and deliver therapy point-by-point, without human intervention.¹⁰

Conclusions: The era of precision medicine is here

Magnetic nanoparticles that travel through the labyrinths of blood vessels are not just another hype, but are ready to change the standard of medicine. Ukrainian specialists, along with laboratories around the world, are developing “addressless” delivery of drugs through the blood, and clinics are preparing for the most massive leap in the treatment of neurodiseases, oncology, and cardiology in the last decade.

Sources

1. phys.org. Magnetic nanoparticles that successfully navigate complex blood vessels may be ready for clinical trials
2. uu.edu.ua. Nanoparticles of magnetic materials will allow delivering drugs to the area of ​​inflammation using a magnetic field
3. pmc.ncbi.nlm.nih.gov. Magnetic nanoparticle transport within flowing blood and into tissue
4. science.org. Clinically ready magnetic microrobots for targeted therapies
5. nature.com. Tiny robots swim through blood, deliver drugs — and then dissolve
6. sciencetimes.com. Can Medical Nanobots Really Navigate the Human Body?
7. worldofextraordinary.com.au. Nanobots Swarm Aneurysms: Tiny Robots Now Crawl Inside Blood Vessels
8. ethz.ch Microrobots finding their way | ETH Zurich
9. pubs.acs.org. Advances in Micro/Nanorobots in Medicine: Design, Actuation, and Medical Applications
10. pubs.rsc.org. Exosome-driven biohybrid nanorobots: bridging nature and precision therapy